Updated Jul 16, 2026
Macrae Sandy has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Sandy Macrae is the President, CEO, and Director of Sangamo Therapeutics, Inc., a genomic medicine company focused on developing transformative therapies for serious neurological diseases. With a strong background in biotechnology and pharmaceuticals, he has been instrumental in advancing the company's innovative pipeline.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 12.6K | $0.17 | $2K |
| 2026-02-27 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 33.6K | $0.47 | $16K |
| 2026-02-27 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 5.3K | $0.47 | $2K |
| 2026-01-26 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 103.0K | $0.40 | $41K |
| 2025-08-24 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 7.5K | $0.59 | $4K |
| 2025-07-22 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 127.0K | $0.48 | $61K |
| 2025-05-24 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 7.5K | $0.47 | $4K |
| 2025-04-22 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 127.0K | $0.78 | $99K |
| 2024-11-26 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 10.6K | $1.94 | $21K |
| 2024-11-26 | SGMO | SANGAMO THERAPEUTICS, INC | F — Tax withholding / forfeiture | 7.5K | $1.88 | $14K |
Sandy Macrae is the President, CEO, and Director of Sangamo Therapeutics, Inc., a genomic medicine company focused on developing transformative therapies for serious neurological diseases. With a strong background in biotechnology and pharmaceuticals, he has been instrumental in advancing the company's innovative pipeline.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Macrae Sandy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.